Godefridus J. Peters

← Back to Vrije Universiteit Amsterdam

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

1. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

   2016 · 5,856 citations

2. Guidelines for the use and interpretation of assays for monitoring autophagy

   2012 · 3,996 citations

3. Fluorouracil: biochemistry and pharmacology.

   1988 · 834 citations

4. MRP3, an organic anion transporter able to transport anti-cancer drugs

   1999 · 645 citations

5. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing

   1991 · 460 citations

6. MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity

   2010 · 457 citations

7. Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein

   2008 · 454 citations

8. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.

   1999 · 440 citations

9. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism

   2002 · 420 citations

10. Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)

    2002 · 360 citations

11. Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance

    2011 · 345 citations

12. Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin

    2002 · 316 citations

13. Interaction between cisplatin and gemcitabine in vitro and in vivo.

    1995 · 313 citations

14. Synergistic interaction between cisplatin and gemcitabine in vitro.

    1996 · 303 citations

15. Basis for effective combination cancer chemotherapy with antimetabolites

    2000 · 302 citations

16. Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer

    2010 · 290 citations

17. Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors

    2002 · 279 citations

18. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers

    2004 · 264 citations

19. 2′,2′-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines

    1993 · 253 citations

20. Analysis of Drug Interactions

    2011 · 252 citations

21. Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

    2016 · 241 citations

22. Platinum-Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future

    2015 · 232 citations

23. Discovery of N -Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform A (LDH-A) as Starvation Agents against Cancer Cells

    2011 · 227 citations

24. Circumvention of Methotrexate Resistance in Childhood Leukemia Subtypes by Rationally Designed Antifolates

    1999 · 215 citations

25. Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

    2008 · 210 citations

← Return to the university profile